phosphatidylcholines has been researched along with Psoriasis in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (42.86) | 18.7374 |
1990's | 1 (7.14) | 18.2507 |
2000's | 1 (7.14) | 29.6817 |
2010's | 5 (35.71) | 24.3611 |
2020's | 1 (7.14) | 2.80 |
Authors | Studies |
---|---|
Davtyan, H; Hakobyan, G; Karapetyan, S; Khachikyan, K | 1 |
Fishman, D; Kingo, K; Okas, TL; Ottas, A; Soomets, U | 1 |
Cheng, TY; Gras, S; Iwany, S; Moody, DB; Rossjohn, J; Shahine, A; Van Rhijn, I | 1 |
Agrawal, U; Gupta, M; Vyas, SP | 1 |
Bhatia, A; Bhushan, S; Katare, OP; Singh, B | 1 |
Kanokpanont, S; Raktanonchai, U; Srisuk, P; Thongnopnua, P | 1 |
ENTICKNAP, JB; LANSLEY, TS; RYAN, CC | 1 |
THORNE, N | 1 |
Abramovich, AI | 1 |
Heitmann, J; Iversen, L; Kragballe, K; Ziboh, VA | 1 |
Antón, R; Camacho, M; Puig, L; Vila, L | 1 |
Gray, GM; Ilderton, E; Summerly, R | 1 |
Brenner, S; Heldenberg, D; Krakowski, A; Levtov, O; Tamir, I; Werbin, B | 1 |
Forster, S; Ilderton, E; Norris, JF; Summerly, R; Yardley, HJ | 1 |
1 trial(s) available for phosphatidylcholines and Psoriasis
Article | Year |
---|---|
Impact of supplemental essential phospholipids on treatment outcome and quality of life of patients with psoriasis with moderate severity.
Topics: Adolescent; Adult; Humans; Phosphatidylcholines; Psoriasis; Quality of Life; Severity of Illness Index; Treatment Outcome | 2022 |
13 other study(ies) available for phosphatidylcholines and Psoriasis
Article | Year |
---|---|
The metabolic analysis of psoriasis identifies the associated metabolites while providing computational models for the monitoring of the disease.
Topics: Adult; Aged; Alkanes; Amino Acids; Carnitine; Computer Simulation; Dicarboxylic Acids; Female; Humans; Male; Metabolome; Middle Aged; Phosphatidylcholines; Phytol; Psoriasis; Urea; Young Adult | 2017 |
A molecular basis of human T cell receptor autoreactivity toward self-phospholipids.
Topics: Animals; Antigens, CD1; Autoantigens; Humans; K562 Cells; Lymphocyte Activation; Mice; Phosphatidylcholines; Phosphatidylethanolamines; Phospholipids; Psoriasis; Receptors, Antigen, T-Cell; Receptors, Antigen, T-Cell, alpha-beta; T-Lymphocytes | 2017 |
Capsaicin delivery into the skin with lipidic nanoparticles for the treatment of psoriasis.
Topics: Administration, Cutaneous; Animals; Antipruritics; Biological Transport; Capsaicin; Drug Carriers; Microscopy, Electron, Transmission; Nanoparticles; Oleic Acid; Particle Size; Phosphatidylcholines; Psoriasis; Rabbits; Rats; Skin; Skin Absorption; Tissue Culture Techniques | 2015 |
Tamoxifen-encapsulated vesicular systems: cytotoxicity evaluation in human epidermal keratinocyte cell line.
Topics: Administration, Cutaneous; Cell Line; Cell Proliferation; Cell Survival; Cholesterol; Drug Carriers; Hexoses; Humans; Inhibitory Concentration 50; Keratinocytes; Liposomes; Membrane Fluidity; Phosphatidylcholines; Psoriasis; Selective Estrogen Receptor Modulators; Surface-Active Agents; Tamoxifen | 2010 |
Physico-chemical characteristics of methotrexate-entrapped oleic acid-containing deformable liposomes for in vitro transepidermal delivery targeting psoriasis treatment.
Topics: Administration, Cutaneous; Animals; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Dermatologic Agents; Diffusion Chambers, Culture; Drug Delivery Systems; Drug Stability; Electrochemistry; Half-Life; In Vitro Techniques; Liposomes; Methotrexate; Oleic Acid; Particle Size; Permeability; Phosphatidylcholines; Phospholipids; Psoriasis; Skin Absorption; Swine | 2012 |
Blood lipids in psoriasis. The effects of "Lipostabil".
Topics: Humans; Lipids; Phosphatidylcholines; Phospholipids; Psoriasis | 1961 |
THE TREATMENT OF PSORIASIS WITH FRACTIONATED TAR AND LECITHIN. PRELIMINARY REPORT.
Topics: Humans; Lecithins; Ointments; Phosphatidylcholines; Psoriasis; Tars | 1963 |
[Use of the preparation Essentiale for treating psoriasis patients].
Topics: Adolescent; Adult; Chronic Disease; Combined Modality Therapy; Drug Evaluation; Female; Humans; Lipids; Lipoproteins; Male; Middle Aged; Phosphatidylcholines; Psoriasis | 1984 |
Incorporation of 15-hydroxyeicosatrienoic acid in specific phospholipids of cultured human keratinocytes and psoriatic plaques.
Topics: 8,11,14-Eicosatrienoic Acid; Anti-Inflammatory Agents, Non-Steroidal; Cells, Cultured; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Humans; Hydroxyeicosatetraenoic Acids; Injections, Intralesional; Keratinocytes; Phosphatidylcholines; Phosphatidylinositols; Phospholipases A; Phospholipases A2; Phospholipids; Psoriasis | 1995 |
Hepoxilin B3 and its enzymatically formed derivative trioxilin B3 are incorporated into phospholipids in psoriatic lesions.
Topics: 8,11,14-Eicosatrienoic Acid; Cytosol; Epidermal Cells; Epidermis; Epoxide Hydrolases; Esterification; Humans; Hydroxyeicosatetraenoic Acids; Phosphatidylcholines; Phosphatidylethanolamines; Phospholipids; Psoriasis; Reference Values; Skin | 2002 |
Possible defects in triacylglycerol and phosphatidylcholine metabolism in psoriatic epidermis.
Topics: Acetates; Epidermis; Humans; In Vitro Techniques; Lipids; Phosphates; Phosphatidylcholines; Phospholipids; Psoriasis; Triglycerides | 1978 |
Serum lipids in patients with psoriasis.
Topics: Adult; Aged; Cholesterol; Fatty Acids, Nonesterified; Female; Heparin; Humans; Lipids; Lysophosphatidylcholines; Male; Middle Aged; Phosphatidylcholines; Phosphatidylethanolamines; Phospholipids; Psoriasis; Sphingomyelins; Time Factors; Triglycerides | 1975 |
Characterization and activity of phospholipase A2 in normal human epidermis and in lesion-free epidermis of patients with psoriasis or eczema.
Topics: Adolescent; Adult; Aged; Calcium; Eczema; Epidermis; Female; Humans; Hydrogen-Ion Concentration; Hydrolysis; Male; Middle Aged; Phosphatidylcholines; Phospholipases; Phospholipases A; Phospholipases A2; Proteins; Psoriasis; Time Factors | 1985 |